Medrise sp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-04-19
Share capital
5,000.00 PLN
Average employment (people)
0.3 (2025)
Activity description

Medrise is a clinical research center established in 2023 by a group of experienced physicians. The company conducts clinical trials for new drugs and therapies targeting various diseases, including ulcerative colitis and Crohn's disease.

Registered address
ul. Onyksowa 10, 20-582 Lublin, Poland
Website
Email
Phone
Electronic delivery address
AE:PL-62269-64515-TBDFW-22

Financials

From the notes

Profit allocationNo decision
Loans and borrowings$148,637
Revenue structuresprzedaż usług

Filing timeliness

Financial statements were filed on time, on average 91 days early.

  • 202507/04/2026
  • 202401/04/2025
  • 202306/05/2024
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 27%
Top 24%
City · Lublin1,619 / 4,827
Top 34%
Voivodeship · Lubelskie3,864 / 10,168
Top 38%
Country · Poland116,531 / 297,069
Top 39%

Results vs industry

Revenue
This companyUSD 571.66kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD 81.39kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 480.59kMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 290.10kMedianUSD 281.58kAverageUSD 8.35m

Authorized Representatives

Wit Cezary Danilkiewicz age 66 – Management Board Member
Maciej Putowski age 33 – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
46$621.2946%
45$607.7845%
Others
9$121.569%

The articles of association require board approval for share transfers.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2023-11-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$22,614

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2025-10-31Switch to PKD 2025
2023-04-19Entered in the register

FAQ

Last updated: 2026-11-05